11 June 2022>: Clinical Research
Efficacy of Focused Extracorporeal Shock Wave Therapy in Chronic Low Back Pain: A Prospective Randomized 3-Month Follow-Up Study
Katarzyna Rajfur 1ABDEF , Joanna Rajfur 1ABDEF , Tomasz Matusz 1ABF , Karolina Walewicz 1ABD , Robert Dymarek 2ABDEFG* , Kuba Ptaszkowski 2ABCD , Jakub Taradaj 3ACDEFGDOI: 10.12659/MSM.936614
Med Sci Monit 2022; 28:e936614
Table 5 ODI scores in both groups.
Variable | Measure | Experimental fESWT group | Control fESWT group | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
χ̄ | Me | Min | Max | Q1 | Q3 | SD | χ̄ | Me | Min | Max | Q1 | Q3 | SD | ||
ODI score | Before | 33.4 | 34.0 | 25.0 | 47.0 | 30.0 | 38.0 | 6.3 | 32.5 | 29.5 | 23.0 | 54.0 | 28.0 | 33.5 | 8.6 |
After | 18.3 | 16.0 | 9.0 | 31.0 | 12.0 | 24.5 | 7.5 | 19.5 | 20.0 | 10.0 | 35.0 | 15.5 | 23.0 | 6.5 | |
1 month FU | 17.3 | 14.0 | 9.0 | 31.0 | 12.0 | 23.0 | 7.1 | 18.7 | 19.0 | 10.0 | 32.0 | 14.0 | 21.0 | 6.6 | |
3 months FU | 18.3 | 16.0 | 11.0 | 31.0 | 12.0 | 24.5 | 6.8 | 19.9 | 19.0 | 10.0 | 36.0 | 15.5 | 23.5 | 7.4 | |
value (main effect)* | |||||||||||||||
p-value (multiple comparisons)** | Before vs after: p | Before vs after: p | |||||||||||||
fESWT – focused extracorporeal shock wave; n – number of individuals; χ̄ – mean; Me – median; Min – minimum value; Max – maximum value; Q1 – lower quartile; Q3 – upper quartile; SD – standard deviation; FU – follow-up. * Friedman’s ANOVA; ** Dunn’s test. |